4-Pyridone-3-carboxamide-1-β-D-ribonucleoside (4PYR)—A Novel Oncometabolite Modulating Cancer-Endothelial Interactions in Breast Cancer Metastasis

The accumulation of specific metabolic intermediates is known to promote cancer progression. We analyzed the role of 4-pyridone-3-carboxamide-1-β-D-ribonucleoside (4PYR), a nucleotide metabolite that accumulates in the blood of cancer patients, using the 4T1 murine in vivo breast cancer model, and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Koszalka, Patrycja, Kutryb-Zajac, Barbara, Mierzejewska, Paulina, Tomczyk, Marta, Wietrzyk, Joanna, Serafin, Pawel K., Smolenski, Ryszard T., Slominska, Ewa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145394/
https://www.ncbi.nlm.nih.gov/pubmed/35628582
http://dx.doi.org/10.3390/ijms23105774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145394/
https://www.ncbi.nlm.nih.gov/pubmed/35628582
http://dx.doi.org/10.3390/ijms23105774

Ejemplares similares